BAFNA PHARMA Share Price
₹ 308.00
+0.00 (0.00%)
1D
Last updated 02 Sep, 2026, 15:15 IST
BAFNA PHARMA Share Price Today
As of 3 Sep 2026, BAFNA PHARMA share price is ₹308.00. The stock opened at ₹306.00, compared to its previous close of ₹308.00. During today's trading session, BAFNA PHARMA share price moved in the range of ₹308.00 to ₹308.00, with an average price of ₹308.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹94.77 and a high of ₹318.50. On the performance front, BAFNA PHARMA share price has increased by 184.95% over the last six months and is up 193.75% on a year-on-year basis.
₹308.00
0.00% up today
₹308.00
1D LOW1D HIGH
Latest Earning
Op Profit TrendUp by 85.18% QoQLatest Earning
Net Profit TrendUp by 72.30% QoQLatest Earning
Revenue TrendUp by 70.07% QoQStock Performance
OutperformingBeat Nifty by 18.31 % in last 1 monthBAFNA PHARMA Returns Calculator
If you would've invested
₹
₹1,000₹1Cr
Historical Returns
1 Year
₹15,28,991+₹10,28,991 (+205.80%)
3 Year
₹18,43,208+₹13,43,208 (+268.64%)
5 Year
₹11,98,910+₹6,98,910 (+139.78%)
Market Overview
About
Fundamentals
Financials
Technicals
Events
FAQs
Open
₹306.00
High
₹308.00
Low
₹308.00
Prev. close
₹308.00
Volume
--
Average traded price
--
Last traded time
03:15:10 02 Sep
Last traded quantity
100
₹301.85₹314.15
Circuit LowCircuit High
₹94.77₹318.50
52-Week Low52-Week High
Circuit
LH
₹301.85
₹314.15
52-week
LH
₹94.77
₹318.50
About BAFNA PHARMA
ISIN
INE878I01022
Sector Market Cap
₹ 2.1 Cr
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
BAFNA PHARMA Financial Highlights
- Revenue: BAFNA PHARMA reported revenue of ₹44.01 crore in FY19 vs ₹78.50 crore in FY18. It showed a decrease of 43.94% on a yearly basis.
- Operating Profit: BAFNA PHARMA reported an operating loss of ₹17.28 crore in FY19 vs ₹14.72 crore in FY18. It showed a decrease of 17.39% on a year-on-year basis.
- Net Profit: BAFNA PHARMA reported a net loss of ₹18.35 crore in FY19 vs ₹16.91 crore in FY18. It showed a decrease of 8.52% on a yearly basis.
BAFNA PHARMA Quarterly Result Highlights
- BAFNA PHARMA reported revenue of ₹12.16 crore in Sep 2019, compared with ₹7.15 crore in Jun 2019, representing an increase of 70.07% on a quarter-on-quarter (QoQ) basis.
- BAFNA PHARMA reported an operating loss of ₹0.55 crore in Sep 2019, compared with ₹3.71 crore in Jun 2019, representing an increase of 85.18% on a quarter-on-quarter (QoQ) basis.
- BAFNA PHARMA reported a loss of ₹0.59 crore in Sep 2019, compared with ₹2.13 crore in Jun 2019, reflecting an increase of 72.30% on a QoQ basis.
- The earnings per share (EPS) of BAFNA PHARMA stood at ₹15.52 during Sep 2019.
Promoters
75.00%
FII
9.34%
Other DII
0.00%
Retail and other
15.66%
Mutual funds
0.00%
Foreign institutions - FII
| Sep 2025 | 9.34% |
|---|---|
| Dec 2025 | 9.34% |
| Mar 2026 | 9.34% |
| Jun 2026 | 9.34% |
BAFNA PHARMA Shareholder Returns
1 day
-1.47%
1 week
+9.76%
1 month
+17.15%
1 year
+193.75%
3 years
+216.22%
5 years
+138.94%
BAFNA PHARMA Share Price History
Day
Open / Close
Change %
02 Sep 26
₹306.35 / ₹308.00
-1.47%
01 Sep 26
₹307.00 / ₹312.60
+2.74%
31 Aug 26
₹298.00 / ₹304.25
+4.52%
28 Aug 26
₹278.00 / ₹291.10
+4.90%
27 Aug 26
₹278.80 / ₹277.50
-1.10%
26 Aug 26
₹280.00 / ₹280.60
+5.00%
25 Aug 26
₹255.00 / ₹267.25
+4.99%
24 Aug 26
₹253.90 / ₹254.55
+4.99%
21 Aug 26
₹232.95 / ₹242.45
+2.00%
20 Aug 26
₹237.70 / ₹237.70
-2.00%
Show more
Mkt Cap Cr
2.10
P/E
93.83
P/B
-0.49
ROE
11.54%
D/E
0.39
ROCE
10.63%
Div. Yield
0.00%
EPS(TTM)
4.69
Turnover
0.81
EV/EBITDA
0.16
Net Margin
7.37%
Op. Margin
13.74%
ROA
-45.61%
Quick Ratio
1.06
Curr. Ratio
2.39
Mkt Cap Cr
2.10
P/E
93.83
P/B
-0.49
ROE
11.54%
D/E
0.39
ROCE
10.63%
Div. Yield
0.00%
EPS(TTM)
4.69
Turnover
0.81
EV/EBITDA
0.16
Net Margin
7.37%
Op. Margin
13.74%
ROA
-45.61%
Quick Ratio
1.06
Curr. Ratio
2.39
Based on fundamentals, this stock's
5/5
Performance
Excellent
Bafna Pharma. outperforming all market indices
3/5
Valuation
Fairly Valued
Bafna Pharma. appears to be fairly valued compared to its peers
3/5
Earnings
Neutral
Bafna Pharma. earnings growth is positive
Peer Comparison
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,180.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,43,302.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,88,623.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,16,114.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,554.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,312.20 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 96,836.10 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
BAFNA PHARMA Financials
Full statement
Income Statement · Consolidated
| Particulars | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|
| Revenue | ₹42.47 | ₹43.63 | ₹47.17 | ₹64.96 |
| Other Income | ₹0.26 | ₹0.39 | ₹31.33 | ₹1.14 |
| Total Revenue | ₹42.73 | ₹44.01 | ₹78.50 | ₹66.10 |
| Total Expenses | ₹44.61 | ₹62.31 | ₹93.22 | ₹86.46 |
| Profit Before Tax | -₹1.88 | -₹18.29 | -₹14.72 | -₹20.36 |
| Tax | ₹0.00 | ₹1.07 | ₹2.19 | -₹0.90 |
| Profit After Tax | -₹1.88 | -₹19.36 | -₹16.91 | -₹19.46 |
| EPS - Basic | -₹15.52 | -₹11.48 | -₹9.24 | -₹10.43 |
| EPS - Diluted | -₹15.52 | -₹11.48 | -₹9.24 | -₹10.43 |
Cash Flow · Consolidated
| Particulars | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|
| Profit before tax | -₹1.88 | -₹18.29 | -₹14.72 | -₹20.36 |
| Income before WC changes | -₹21.34 | -₹12.84 | -₹34.24 | -₹4.86 |
| Change in Assets | ₹18.14 | ₹0.03 | ₹28.74 | ₹15.55 |
| Change in Liabilities | -₹31.11 | ₹11.03 | -₹1.54 | -₹11.64 |
| Change in WC | -₹12.97 | ₹11.06 | ₹27.20 | ₹3.91 |
| Cash flow from Operations | -₹34.31 | -₹1.79 | -₹7.05 | -₹0.95 |
| Cash flow from Investing | ₹32.77 | ₹15.36 | ₹37.97 | -₹5.42 |
| Cash flow from Financing | ₹7.30 | -₹13.81 | -₹30.63 | ₹6.31 |
| Total Cash Flow | ₹5.77 | -₹0.24 | ₹0.29 | -₹0.06 |
| Cash (Start of the year) | ₹2.71 | ₹2.95 | ₹2.66 | ₹2.71 |
| Cash (End of the year) | ₹8.48 | ₹2.71 | ₹2.95 | ₹2.66 |
Balance Sheet · Consolidated
| Particulars | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|
| Non-Current Assets | ₹35.22 | ₹71.00 | ₹89.62 | ₹101.12 |
| Current Assets | ₹36.10 | ₹48.47 | ₹48.74 | ₹77.18 |
| Total Assets | ₹71.31 | ₹119.47 | ₹138.36 | ₹178.31 |
| Current Liabilities | ₹17.10 | ₹70.82 | ₹59.85 | ₹81.47 |
| Net Current Asset | ₹19.00 | -₹22.35 | -₹11.11 | -₹4.29 |
| Non-Current Liabilities | ₹3.02 | ₹29.80 | ₹41.31 | ₹54.72 |
| Equity Capital | ₹51.20 | ₹18.85 | ₹37.20 | ₹42.11 |
| Total Equity & Liabilities | ₹71.31 | ₹119.47 | ₹138.36 | ₹178.31 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹150.62 | ₹145.86 | ₹152.47 | ₹115.35 |
| Other Income | ₹4.76 | ₹2.74 | ₹3.52 | ₹3.27 |
| Total Revenue | ₹155.37 | ₹148.60 | ₹155.99 | ₹118.62 |
| Total Expenses | ₹144.40 | ₹142.30 | ₹148.64 | ₹107.01 |
| Profit Before Tax | ₹10.97 | ₹4.15 | ₹7.35 | ₹11.62 |
| Tax | -₹0.13 | ₹0.00 | ₹0.00 | ₹0.28 |
| Profit After Tax | ₹11.10 | ₹4.15 | ₹7.35 | ₹11.34 |
| EPS - Basic | ₹4.69 | ₹1.76 | ₹3.11 | ₹4.79 |
| EPS - Diluted | ₹4.69 | ₹1.76 | ₹3.11 | ₹4.79 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹10.97 | ₹4.15 | ₹7.35 | ₹11.62 |
| Income before WC changes | ₹20.65 | ₹14.24 | ₹14.94 | ₹19.50 |
| Change in Assets | -₹5.43 | ₹10.47 | -₹14.19 | -₹30.15 |
| Change in Liabilities | -₹0.17 | -₹2.92 | ₹8.91 | ₹15.73 |
| Change in WC | -₹5.60 | ₹7.55 | -₹5.28 | -₹14.42 |
| Cash flow from Operations | ₹15.37 | ₹22.14 | ₹9.48 | ₹4.95 |
| Cash flow from Investing | -₹22.40 | -₹21.16 | -₹15.05 | -₹7.49 |
| Cash flow from Financing | ₹5.62 | ₹1.06 | -₹0.85 | ₹10.18 |
| Total Cash Flow | -₹1.41 | ₹2.04 | -₹6.41 | ₹7.64 |
| Cash (Start of the year) | ₹3.43 | ₹1.40 | ₹7.81 | ₹0.17 |
| Cash (End of the year) | ₹2.02 | ₹3.43 | ₹1.40 | ₹7.81 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹85.88 | ₹68.35 | ₹53.91 | ₹42.27 |
| Current Assets | ₹89.65 | ₹84.73 | ₹93.77 | ₹87.31 |
| Total Assets | ₹175.53 | ₹153.08 | ₹147.68 | ₹129.58 |
| Current Liabilities | ₹57.19 | ₹51.85 | ₹54.08 | ₹46.48 |
| Net Current Asset | ₹32.46 | ₹32.88 | ₹39.69 | ₹40.84 |
| Non-Current Liabilities | ₹22.19 | ₹16.42 | ₹12.76 | ₹9.65 |
| Equity Capital | ₹96.15 | ₹84.81 | ₹80.84 | ₹73.45 |
| Total Equity & Liabilities | ₹175.53 | ₹153.08 | ₹147.68 | ₹129.58 |
* All values are in INR Crore
Qty
Bid
3
311.05
10
309
380
308
55
307.5
300
306
Ask
Qty
301.85
45
305
475
306.5
45
308
101
310
144
Bid Total: 748
Ask Total: 810
Buy orders: 48%
Sell orders: 52%
30 levels of bid & ask depth
Supply & Demand Zones
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts available for this stock
Earn more using advisory
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
72.34
Bullish
ATR (14)
9.97
Neutral
STOCH(9,6)
87.73
Bearish
STOCH RSI (14)
89.56
Bearish
ADX(9)
34.71
Bearish
UO(9)
77.17
Bearish
ROC(12)
21.96
Bullish
WillR(14)
-12.27
Bearish
Period
Simple value
Exponential vaue
5D
298.69
298.92
10D
277.6
286.36
20D
271.51
273.46
50D
245.48
244.64
100D
194.81
211.83
| 2 Sep | 0L |
|---|---|
| 1 Sep | 0L |
| 31 Aug | 0L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Compare against other stocks
BAFNA PHARMA
Pharmaceuticals
Add Stock
Add Another
Top Gainers
Popular Stocks
YES Bank Share Price
YESBANK
₹22.32
+0.17 (0.77%)
Tata Power Share Price
TATAPOWER
₹369.75
+5.75 (1.58%)
Tata Motors Share Price
TMPV
₹313.00
+0.25 (0.08%)
Trident Share Price
TRIDENT
₹24.16
+0.10 (0.42%)
Tata Steel Share Price
TATASTEEL
₹186.22
+2.37 (1.29%)
Vodafone Idea Share Price
IDEA
₹14.56
+0.03 (0.21%)
Suzlon Energy Share Price
SUZLON
₹45.91
+0.45 (0.99%)
IRFC Share Price
IRFC
₹83.11
+0.63 (0.76%)
Indian Oil Share Price
IOC
₹137.38
+0.38 (0.28%)
Jaiprakash Power Ventures Share Price
JPPOWER
₹16.45
+0.08 (0.49%)
BAFNA PHARMA Share Price FAQs
What is BAFNA PHARMA share price today?
BAFNA PHARMA share price is ₹308.00 as on 02 Sep, 2026, 15:15 IST.
How has the BAFNA PHARMA share price performed in the past?
In the last 1 year, BAFNA PHARMA delivered a return of 193.75%. The BAFNA PHARMA share price hit a high of ₹318.50 and low of ₹94.77.
How much is the Mutual Fund shareholding in BAFNA PHARMA shares?
The Mutual Fund Shareholding in BAFNA PHARMA was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of BAFNA PHARMA shares ?
The 52-week high and low of BAFNA PHARMA share is ₹318.50 and ₹94.77 as of 02 Sep, 2026.
What is the market cap of BAFNA PHARMA?
The market capitalisation of BAFNA PHARMA is ₹2.10 Crores as on 02 Sep, 2026.
What are the stock symbols of BAFNA PHARMA?
The stock symbol of BAFNA PHARMA is BAFNAPH on the NSE, 532989 on the BSE, and the ISIN is INE878I01022.
What was yesterday's closing price of BAFNA PHARMA shares ?
BAFNA PHARMA shares closed yesterday at ₹308.00 on NSE & ₹308.70 on BSE
How to buy BAFNA PHARMA shares?
To buy BAFNA PHARMA shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy BAFNA PHARMA shares on Holidays?
No, shares of BAFNA PHARMA or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell BAFNA PHARMA shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of BAFNA PHARMA?
The PE and PB ratio of BAFNA PHARMA is 93.83 and -0.49 respectively, as on 02 Sep, 2026, 15:15 IST.